Researchers develop first-in-class inhibitors against key leukemia protein
Herd immunity appears unlikely for COVID-19, but CDC says vaccinated people can ditch masks in most settings
14 May 2021New study into pediatric intensive care paves the way for improving care for critically ill children
14 May 2021Researchers develop first-in-class inhibitors against key leukemia protein
The protein made by the ASH1L gene plays a key role in the development of acute leukemia, along with other diseases. The ASH1L protein, however, has been challenging to target therapeutically.
